Showing 1 to 4 of 4 results


Medicaid Cuts to Cause Widespread Healthcare Disruption
The "Big Beautiful Bill" will cut \$1 trillion in Medicaid spending by 2034, potentially causing 15.9 million Americans to lose coverage and 477,000 healthcare jobs, while also impacting rural hospitals.
Medicaid Cuts to Cause Widespread Healthcare Disruption
The "Big Beautiful Bill" will cut \$1 trillion in Medicaid spending by 2034, potentially causing 15.9 million Americans to lose coverage and 477,000 healthcare jobs, while also impacting rural hospitals.
Progress
48% Bias Score


Market Volatility: Quantum, Semiconductor, and Biotech Stocks Plunge
Midday market trading saw significant drops in quantum computing stocks (Rigetti -27%, D-Wave -32%), semiconductor stocks (Nvidia -2%, Micron -5%), and Moderna (-20%) due to lowered expectations, export restrictions, and reduced sales guidance, respectively; however, some companies like Howard Hughe...
Market Volatility: Quantum, Semiconductor, and Biotech Stocks Plunge
Midday market trading saw significant drops in quantum computing stocks (Rigetti -27%, D-Wave -32%), semiconductor stocks (Nvidia -2%, Micron -5%), and Moderna (-20%) due to lowered expectations, export restrictions, and reduced sales guidance, respectively; however, some companies like Howard Hughe...
Progress
36% Bias Score

Healthcare Stocks Underperform Amidst Medicaid Cut Concerns
Investor concerns about Medicaid cuts and "big beautiful bill" adjustments caused major healthcare stocks like Eli Lilly, Johnson & Johnson, AbbVie, and Amgen to underperform the S&P 500 and Nasdaq 100, leading to significant share price drops in April 2025 despite brief rallies.

Healthcare Stocks Underperform Amidst Medicaid Cut Concerns
Investor concerns about Medicaid cuts and "big beautiful bill" adjustments caused major healthcare stocks like Eli Lilly, Johnson & Johnson, AbbVie, and Amgen to underperform the S&P 500 and Nasdaq 100, leading to significant share price drops in April 2025 despite brief rallies.
Progress
40% Bias Score

Australian Tech and Healthcare Stocks Soar in 2024
Australian technology and healthcare stocks soared in 2024, with ZipCo leading at 364% growth, followed by Life360 (201%), Sigma Healthcare (163%), Pro Medicus (166%), and Telix Pharma (146%), significantly outpacing the S&P/ASX200's 7.6% increase, driven by investor confidence and demographic trend...

Australian Tech and Healthcare Stocks Soar in 2024
Australian technology and healthcare stocks soared in 2024, with ZipCo leading at 364% growth, followed by Life360 (201%), Sigma Healthcare (163%), Pro Medicus (166%), and Telix Pharma (146%), significantly outpacing the S&P/ASX200's 7.6% increase, driven by investor confidence and demographic trend...
Progress
48% Bias Score
Showing 1 to 4 of 4 results